Get investor ideas from our AI, cannabis, cleantech, crypto, gaming, mining, sports podcasts - be a guest or sponsor: call 800 665 0411

Share on StockTwits

AI Eye Episode 427: iRhythm (NasdaqGS: $IRTC) Wins NHS Funding Through AI Healthcare Award and BlackBerry's (NYSE: $BB) QNX Platform to be Leveraged by StradVision


Point Roberts, WA and Vancouver, BC - September 8, 2020 ( Newswire) (, a global investor news source covering Artificial Intelligence (AI) brings you today's edition of The AI Eye - watching stock news, deal tracker and advancements in artificial intelligence.

Listen to today's podcast:

AI Eye Episode 427: iRhythm (NasdaqGS: $IRTC) Wins NHS Funding Through AI Healthcare Award and BlackBerry's (NYSE: $BB) QNX Platform to be Leveraged by StradVision


Hear the AI Eye on Spotify

Today's Column - The AI Eye - Watching stock news, deal tracker and advancements in artificial intelligence

Stocks discussed: (NasdaqGS:IRTC) (NYSE:BB)

Digital healthcare solutions firm iRhythm Technologies, Inc. (NasdaqGS:IRTC) has won the Artificial Intelligence (AI) in Health and Care Award in a competitive process run by the UK's NHS AI Lab, by "combining the power of artificial intelligence with the expertise of the NHS to improve health and care outcomes." The company will consequently receive NHS funding, which it will use to trial its Zio service, described in the press release as "a small, discreet and easy-to-use cardiac monitoring service, used to detect a range of arrhythmias quickly and accurately," which is underpinned by AI. iRhythm's GM and VP EMEA, Justin Hall, said:

"The UK is home to some of the most cutting-edge, life-changing medical technologies. However, it is still taking years for medical devices to go from clinical trial to wide-spread adoption, meaning neither patients nor practitioners are seeing the many benefits of these innovations. We're absolutely delighted to have been chosen as part of the pilot to change that."

BlackBerry Limited (NYSE:BB) has announced that AI-based camera perception technology leader StradVision has selected its QNX Software Development Platform for utilization within a number of next generation Advanced Driver Assistance Systems (ADAS) and Autonomous Vehicles (AV) from South Korean automakers. Junhwan Kim, CEO, StradVision, commented:

"The competitiveness of SVNet lies in its flexibility with its broad hardware support and deep learning software for the advancement of safer driving. Leveraging BlackBerry technology will reinforce SVNet as one of the most reliable, safe and robust camera perception solutions for ADAS & Autonomous Vehicles, enabling us to bring more innovation and convenience to customers."

AI in Life Sciences Market to Reach $4.893 Billion by 2025

A report from Mordor Intelligence finds that the global AI in Life Sciences market will grow from $1.101 billion in 2019 to $4.893 billion by 2025 with a compound annual growth rate (CAGR) of 29.42 percent in the forecast period 2020-2025. An excerpt from the report snapshot outlines the impact of AI being leveraged for clinical trials:

Clinical trial research is an extensive progress, which can be reduced with the help of AI in numerous ways. One is by using advanced predictive analytics on a broad range of data to identify candidates for clinical trials for target populations more quickly. Additionally, machine learning applications can make clinical trials more efficient by facilitating tasks, such as calculating ideal sample sizes, facilitating patient recruitment, and using medical records to minimize data errors.

Sam Mowers,

Read and hear other editions of the AI Eye

For a list of artificial intelligence stocks on visit here or become an Investor Ideas member

About - News that Inspires Big Investing Ideas is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea's original branded content includes the following podcasts and columns: Crypto Corner, Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change, Exploring Mining the AI Eye.

The podcasts are also available on iTunes, Spotify, Tunein, Stitcher,, iHeartRadio and Google Play Music.

Visit the Podcast page at

Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: Learn more about publishing your news release and our other news services on the newswire and

Global investors must adhere to regulations of each country. Please read privacy policy:

The AI Eye - Watching stock news, deal tracker and advancements in artificial intelligence is an original content brand of

Follow us on Twitter

Follow us on Facebook

Follow us on YouTube

Download our Mobile App for iPhone and Android


800 665 0411

Get more tech stocks investor ideas - news, articles, podcasts and stock directories

Buy a technology guest post on